ReShape Lifesciences Inc. (RSLS), on Thursday announced it has entered into an exclusive U.S. distribution agreement with Recon Supply to expand access to its medical device portfolio across the Veterans Administration or VA and Department of Defense or DoD healthcare systems.
Under the agreement, Recon Supply becomes the exclusive distributor of ReShape's full product line, including the FDA-cleared STIMEL-03 neuromuscular rehabilitation device and the next-generation Lap-Band 2.0 FLEX system, to VA and DoD medical facilities.
The partnership aims to broaden the availability of clinically proven technologies to more than 18 million U.S. veterans and active-duty service members.
Recon Supply, a Service-Disabled Veteran-Owned Small Business or SDVOSB, currently distributes to 102 VA Medical Centers and holds federal contracts such as DAPA, FSS, and ECAT, which enable streamlined procurement across government health systems.
STIMEL-03 is a neurorehabilitation device that combines real-time EMG biofeedback with personalized electrical stimulation, designed to support recovery from stroke, surgery, or injury.
The Lap-Band 2.0 FLEX provides a minimally invasive, adjustable weight-loss option and is part of ReShape's broader portfolio of solutions targeting obesity and metabolic disorders.
"This agreement with Recon Supply marks a pivotal step forward in ReShape's mission to expand access to innovative medical technologies that improve lives," said Paul F. Hickey, President and CEO of ReShape Lifesciences.
He added that, "Through Recon's established federal presence, we can now deliver our leading-edge devices to veterans and military personnel across the country.
Currently, RSLS is trading at $3.49, up by 55.91 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.